Controlled Trial of Continuous Positive Airway Pressure in Obstructive Sleep Apnea and Heart Failure
American Journal of Respiratory and Critical Care MedicinePublished 3 November 2003
Darren Mansfield, Nathan Gollogly, David M. Kaye, Meroula Richardson, Peter Bergin, Matthew T. Naughton
Citations619
SJR quartileQ1
SJR score5.08
SNIP3.86
Generate an AI Snapshot to get a quick, structured summary of this paper.
Study Snapshot
ObjectiveStudy objective
MethodsResearch methodology
PopulationPopulation studied
Sample sizeSample sizes
OutcomesStudy outcomes here
ResultsStudy results comes here
LimitationsResearch study limitations comes here
A concise AI-generated summary of the paper will appear here once you click Generate AI Snapshot.
TL;DR
Treatment of OSA among patients with CHF leads to improvement in cardiac function, sympathetic activity, and quality of life, and there were no significant changes in systemic blood pressure.
Abstract
Obstructive sleep apnea (OSA) is highly prevalent among patients with congestive heart failure (CHF) and may contribute to progression of cardiac dysfunction via hypoxia, elevated sympathetic nervous system activity, and systemic hypertension. Our aim was to assess the long-term effect of OSA treatment with nocturnal continuous positive airway pressure (CPAP) on systolic heart function, sympathetic activity, blood pressure, and quality of life in patients with CHF. Fifty-five patients with CHF and OSA were randomized to 3 months of CPAP or control groups. End points were changes in left ventricular ejection fraction, overnight urinary norepinephrine excretion, blood pressure, and quality of life. Nineteen patients in the CPAP group and 21 control subjects completed the study. Compared with the control group, CPAP treatment was associated with significant improvements in left ventricular ejection fraction (delta 1.5 +/- 1.4% vs. 5.0 +/- 1.0%, respectively, p = 0.04), reductions in overnight urinary norepinephrine excretion (delta 1.6 +/- 3.7 vs. -9.9 +/- 3.6 nmol/mmol creatinine, p = 0.036), and improvements in quality of life. There were no significant changes in systemic blood pressure. In conclusion, treatment of OSA among patients with CHF leads to improvement in cardiac function, sympathetic activity, and quality of life.
Keywords
MedicineNeuroscience
SLEEPA New Method for Measuring Daytime Sleepiness: The Epworth Sleepiness Scale
17,210 Citations1991Murray W. Johns
The development and use of a new scale, the Epworth sleepiness scale (ESS), is described, which is a simple, self-administered questionnaire which is shown to provide a measurement of the subject's general level of daytime sleepiness.
New England Journal of MedicineProspective Study of the Association between Sleep-Disordered Breathing and Hypertension
4,975 Citations2000Paul E. Peppard, Terry Young +2 more
A dose-response association between sleep-disordered breathing at base line and the presence of hypertension four years later was found that was independent of known confounding factors and suggest that sleep- disordered breathing is likely to be a risk factor for hypertension and consequent cardiovascular morbidity in the general population.
New England Journal of MedicineObesity and the Risk of Heart Failure
2,956 Citations2002Satish Kenchaiah, Jane C. Evans +6 more
In this large, community-based sample, increased body-mass index was associated with an increased risk of heart failure and strategies to promote optimal body weight may reduce the population burden ofheart failure.
American Journal of Respiratory and Critical Care MedicineSleep-disordered Breathing and Cardiovascular Disease
2,913 Citations2001Eyal Shahar, Coralyn W. Whitney +8 more
Findings are compatible with modest to moderate effects of sleep-disordered breathing on heterogeneous manifestations of CVD within a range of AHI values that are considered normal or only mildly elevated.
New England Journal of MedicineA Comparison of Enalapril with Hydralazine–Isosorbide Dinitrate in the Treatment of Chronic Congestive Heart Failure
2,836 Citations1991Jay N. Cohn, Gary R. Johnson +17 more
The different effects of the two regimens (enalapril and hydralazine-isosorbide dinitrate) on mortality and physiologic end points suggest that the profile of effects might be enhanced if the regimens were used in combination.
Journal of Clinical InvestigationSympathetic neural mechanisms in obstructive sleep apnea.
2,499 Citations1995Virend K. Somers, Mark Eric Dyken +2 more
New England Journal of MedicineLong-Term Trends in the Incidence of and Survival with Heart Failure
2,140 Citations2002Daniel Levy, Satish Kenchaiah +6 more
Over the past 50 years, the incidence ofheart failure has declined among women but not among men, whereas survival after the onset of heart failure has improved in both sexes.
The LancetMorbidity and mortality in the Swedish Trial in Old Patients with Hypertension (STOP-Hypertension)
1,888 Citations1991Björn Dahlöf, L. Hansson +4 more
It is concluded that antihypertensive treatment in hypertensive men and women aged 70-84 confers highly significant and clinically relevant reductions in cardiovascular morbidity and mortality as well as in total mortality.
New England Journal of MedicineIs the Placebo Powerless?
1,500 Citations2001Asbjørn Hróbjartsson, Peter C Gøtzsche
CirculationSleep Apnea in 81 Ambulatory Male Patients With Stable Heart Failure
1,162 Citations1998Shahrokh Javaheri, T. Jeffery Parker +5 more
Sleep disruption and arterial oxyhemoglobin desaturation were significantly more severe and the prevalence of atrial fibrillation and ventricular arrhythmias were greater in group 2 than in group 1.
American Journal of Respiratory and Critical Care MedicineRisk Factors for Central and Obstructive Sleep Apnea in 450 Men And Women with Congestive Heart Failure
1,133 Citations1999Don D. Sin, Fabia S. Fitzgerald +4 more
It is concluded that historical information, supplemented by a few simple laboratory tests may enable physicians to risk stratify CHF patients for the presence of CSA or OSA, and the need for diagnostic polysomnography for such patients.
The LancetAmbulatory blood pressure after therapeutic and subtherapeutic nasal continuous positive airway pressure for obstructive sleep apnoea: a randomised parallel trial
1,051 Citations2002Justin CT Pepperell, Sharon Ramdassingh-Dow +5 more
In patients with most severe sleep apnoea, nCPAP reduces blood pressure, providing significant vascular risk benefits, and substantially improving excessive daytime sleepiness and quality of life.
New England Journal of MedicineCardiovascular Effects of Continuous Positive Airway Pressure in Patients with Heart Failure and Obstructive Sleep Apnea
1,043 Citations2003Yasuyuki Kaneko, John S. Floras +6 more
In medically treated patients with heart failure, treatment of coexisting obstructive sleep apnea by continuous positive airway pressure reduces systolic blood pressure and improves left ventricular syStolic function.
CirculationEffect of Nasal Continuous Positive Airway Pressure Treatment on Blood Pressure in Patients With Obstructive Sleep Apnea
928 Citations2003Heinrich F. Becker, Andreas Jerrentrup +5 more
Effective nCPAP treatment in patients with moderate to severe OSA leads to a substantial reduction in both day and night arterial blood pressure, and the fact that a 50% reduction in the apnea-hypopnea index did not result in a decrease in blood pressure emphasizes the importance of highly effective treatment.
CirculationAdrenergic effects on the biology of the adult mammalian cardiocyte.
872 Citations1992Douglas L. Mann, Robert L. Kent +2 more
These results constitute the initial demonstration at the cellular level that adrenergic stimulation leads to cyclic AMP-mediated calcium overload of the cell, with a resultant decrease in synthetic activity and/or viability.
The LancetComparison of therapeutic and subtherapeutic nasal continuous positive airway pressure for obstructive sleep apnoea: a randomised prospective parallel trial
831 Citations1999Crispin Jenkinson, Robert J. Davies +2 more
The effects of therapeutic NCPAP reduces excessive daytime sleepiness and improves self-reported health status compared with a subtherapeutic control and confirms previous uncontrolled clinical observations and the results of controlled trials that used an oral placebo.
Journal of Clinical InvestigationObstructive sleep apnea as a cause of systemic hypertension. Evidence from a canine model.
702 Citations1997Dina Brooks, Richard L. Horner +3 more
The demonstration that OSA can lead to the development of sustained hypertension has considerable importance, given the high prevalence of both disorders in the population.
CirculationDouble-Blind, Placebo-Controlled Study of the Effects of Carvedilol in Patients With Moderate to Severe Heart Failure
617 Citations1996Milton Packer, Wilson S. Colucci +17 more
These findings indicate that, in addition to its favorable effects on survival, carvedilol produces important clinical benefits in patients with moderate to severe heart failure treated with digoxin, diuretics, and an ACE inhibitor.
The LancetRandomised, placebo-controlled trial of carvedilol in patients with congestive heart failure due to ischaemic heart disease
585 Citations1997Australia/New Zealand Heart Failure Research Collaborative Group, -
There was an overall reduction in events resulting in death or hospital admission, and a year of treatment with carvedilol resulted in the avoidance of one such serious event among every 12–13 of these patients with chronic stable heart failure.
American Journal of Respiratory and Critical Care MedicineRandomized Placebo-controlled Crossover Trial of Continuous Positive Airway Pressure for Mild Sleep Apnea/Hypopnea Syndrome
564 Citations1999Heather M. Engleman, Ruth N. Kingshott +4 more
In 14 patients with AHI in the range 5 to 10, symptoms, cognitive function, psychological well-being and quality of life were improved, and unacceptability of CPAP in many such patients is highlighted.
CirculationExercise Anaerobic Threshold and Ventilatory Efficiency Identify Heart Failure Patients for High Risk of Early Death
491 Citations2002Anselm K. Gitt, Karlman Wasserman +7 more
American Journal of Respiratory and Critical Care MedicineCirculating Nitric Oxide is Suppressed in Obstructive Sleep Apnea and is Reversed by Nasal Continuous Positive Airway Pressure
473 Citations2000Msm Ip, Bing Lam +5 more
It is demonstrated, for the first time, that circulating NO is suppressed in OSA, and this is promptly reversible with the use of nCPAP.
American Journal of Respiratory and Critical Care MedicineEffects of Nasal CPAP on Sympathetic Activity in Patients With Heart Failure and Central Sleep Apnea
470 Citations1995Matthew T. Naughton, Dean Benard +4 more
In patients with CHF, CSR-CSA is associated with elevated sympathoneural activity, which can be reduced by NCPAP, which was attenuated in the NCP AP but not in the control group.
CirculationEffect of Continuous Positive Airway Pressure on Intrathoracic and Left Ventricular Transmural Pressures in Patients With Congestive Heart Failure
468 Citations1995Matthew T. Naughton, Mohammad A. Rahman +3 more
In patients with CHF, the inspiratory muscles generate greater force per breath and systolic Pes contributes more to LVPtm than in healthy subjects, and CPAP had no effect on these variables in the healthy subjects.
CirculationInfluence of Pulmonary Capillary Wedge Pressure on Central Apnea in Heart Failure
440 Citations1999Peter Solin, Peter Bergin +4 more
PCWP is elevated in CHF patients with central apneas compared with those with obstructive apnea or without apnea and a highly significant relationship exists between PCWP, hypocapnia, and central apnea frequency and severity.
The LancetObstructive sleep apnoea in patients with dilated cardiomyopathy: effects of continuous positive airway pressure
356 Citations1991R Rutherford, A Xie +4 more
American Journal of Respiratory and Critical Care MedicineTreatment of Congestive Heart Failure and Cheyne-Stokes Respiration during Sleep by Continuous Positive Airway Pressure
345 Citations1995Matthew T. Naughton, P P Liu +3 more
Journal of General Internal MedicineDevelopment and testing of a new measure of health status for clinical trials in heart failure
335 Citations1989Gordon H. Guyatt, Sharon Nogradi +4 more
The authors develop a new measure of subjective health status for patients with heart failure that shows moderate correlations with patient global ratings, walk test scores, and clinical assessments of heart failure, and conclude that it may be useful for measuring health status in clinical trials in heart failure.
Journal of Applied PhysiologyCombined hypoxia and hypercapnia evokes long-lasting sympathetic activation in humans
255 Citations1995Barbara J. Morgan, David C. Crabtree +2 more
American Journal of Respiratory and Critical Care MedicineDepressed Baroreflex Sensitivity in Patients With Obstructive Sleep Apnea
240 Citations1996Jan Carlson, Jan Hedner +3 more
It is concluded that OSA patients exhibit an impaired baroreflex sensitivity to a hypotensive stimulus, which may represent an adaptive response to changes in BP or hypoxemia occurring in association with nocturnal apneas.
American Journal of Respiratory and Critical Care MedicineNontuberculous Mycobacteria: II: Nested-Cohort Study of Impact on Cystic Fibrosis Lung Disease
195 Citations2003Kenneth N. Olivier, David J. Weber +6 more
The Cystic Fibrosis/Pulmonary Research and Treatment Center, the Departments of Epidemiology and Biostatistics, and the Verne S. Caviness General Clinical Research Center are involved in the research.
CHEST JournalLeft Ventricular Systolic Dysfunction in Patients with Obstructive Sleep Apnea Syndrome
175 Citations2002Jean-Pierre Laaban, Sophie Pascal-Sebaoun +4 more
OSAS may be a direct cause of daytime LV systolic dysfunction that can resolve following reversal of nocturnal apneas and can detect silent heart disease, especially coronary artery disease.
American Journal of Respiratory and Critical Care MedicineAcute and Chronic Effects of Airway Obstruction on Canine Left Ventricular Performance
163 Citations1999John D. Parker, Dina Brooks +5 more
It is concluded that in chronic OSA acute airway occlusion during sleep is associated with increases in LV afterload and decreases in fractional shortening and Chronic OSA also leads to sustained decreases in LV systolic performance.
European Respiratory JournalEvidence for left ventricular dysfunction in patients with obstructive sleep apnoea syndrome
126 Citations2002Manos Alchanatis, Georgia Tourkohoriti +6 more
Obstructive sleep apnoea patients without any cardiovascular disease seem to develop left ventricular systolic and diastolic dysfunction, which may be reversed, either partially or completely, after 6 months of continuous positive airway pressure treatment.
European Heart JournalEffect of vasodilator therapy on mortality in chronic congestive heart failure
124 Citations1988Jay N. Cohn, The Veterans Administration Cooperative Study Group
The most likely explanation for the prolonged survival on the effective vasodilator regimen is that these drugs tend to increase left ventricular ejection fraction, probably by a sustained effect on preload and impedance.
CirculationAcute Effects of Continuous Positive Airway Pressure on Cardiac Sympathetic Tone in Congestive Heart Failure
122 Citations2001David M. Kaye, Darren Mansfield +3 more
The short-term application of CPAP results in an inhibition of cardiac sympathetic nervous activity, and further investigation into the potential value of long-term CPAP in CHF patients is warranted.
CHEST JournalImpact of Sleep Apnea on Sympathetic Nervous System Activity in Heart Failure
106 Citations2003Peter Solin, David M. Kaye +4 more
Overnight SNSA is significantly greater in CHF patients than in OSA patients, and the hemodynamic severity of CHF contributes to the elevation of SNSA inCHF patients to a greater degree than apnea-related hypoxemia.
The Medical Journal of AustraliaISOTOPE ANGIOCARDIOGRAPHY OF THE LEFT VENTRICLE
1 Citations1980Aubrey Pitt, Victor Kalff +4 more
Radionuclide imaging of the left ventricle is a recent innovative procedure requiring a gamma‐camera interfaced to a computer and will have increasing application in assessing the aetiology of chest pain, in selection of patients for cardiac surgery, and in determining the effects of interventions on ventricular performance.